(Q74455147)
Statements
Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer (English)
R F Marschke
J P Grill
J A Sloan
D B Wender
R Levitt
J A Mailliard
J B Gerstner
C Ghosh
1 February 1999